Complete Filing Data
Renalytix plc reported Stockholders Equity of $30.61 million for FY2022.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Renalytix plc did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Net Income Loss | -$33.5M | -$45.6M | -$45.3M | -$35.3M | -$9.8M | -$42.3M |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$298.0K | -$198.0K | -$9.7M | $9.4M | -$378.0K | -$826.0K |
| Research And Development Expense Excluding Acquired In Process Cost | $9.3M | $14.3M | $14.6M | $10.0M | $4.6M | $4.3M |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | -$298.0K | -$198.0K | -$9.7M | $9.5M | -$378.0K | -$826.0K |
| Operating Income Loss | -$29.6M | -$42.2M | -$53.2M | -$31.9M | -$10.3M | -$42.3M |
| General And Administrative Expense | $19.8M | $28.7M | $39.5M | $23.5M | $5.8M | $2.7M |
| Operating Expenses | $29.8M | $42.9M | $54.1M | $32.5M | $10.3M | -$42.3M |
| Income Loss From Equity Method Investments | $0.00 | -$9.0K | $9.0K | -$2.1M | -$63.0K | |
| Revenues | $2.3M | $3.4M | $3.0M | $1.5M | $0.00 | |
| Gross Profit | $156.0K | $720.0K | $874.0K | $633.0K | $0.00 | |
| Cost Of Revenue | $2.1M | $2.7M | $2.1M | $858.0K | $0.00 | |
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | $33.4M | $46.1M | $54.5M | -$72.0K | $0.00 | |
| Other Nonoperating Income Expense | $249.0K | $656.0K | $726.0K | $289.0K | $18.0K | |
| Income Tax Expense Benefit | $4.0K | $2.0K | $25.0K | $0.00 | $0.00 | |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$33.5M | -$45.6M | -$45.3M | -$35.3M | -$9.8M | |
| Comprehensive Income Net Of Tax | -$54.5M | -$25.8M | -$10.2M | -$43.1M | ||
| Net Income Loss Available To Common Stockholders Basic | -$45.3M | -$34.7M | -$9.8M | -$42.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|
| Net Income Loss | -$4.7M | -$7.7M | -$8.5M | -$10.2M | -$12.1M | -$10.4M | -$12.0M |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$454.0K | $21.0K | -$401.0K | $42.0K | $593.0K | $588.0K | -$1.1M |
| Research And Development Expense Excluding Acquired In Process Cost | $921.0K | $2.2M | $3.2M | $2.8M | $3.9M | $3.3M | $3.8M |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | -$461.0K | $21.0K | -$401.0K | $42.0K | $505.0K | $588.0K | -$1.1M |
| Operating Income Loss | -$4.1M | -$6.6M | -$8.6M | -$8.9M | -$10.9M | -$9.6M | -$11.7M |
| General And Administrative Expense | $3.3M | $3.9M | $5.3M | $6.1M | $7.1M | $6.8M | $8.3M |
| Operating Expenses | $4.2M | $6.5M | $8.9M | $8.8M | $11.0M | $10.1M | $12.0M |
| Income Loss From Equity Method Investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$9.0K | |
| Revenues | $522.0K | $535.0K | $709.0K | $459.0K | $724.0K | $1.2M | $969.0K |
| Gross Profit | $100.0K | -$66.0K | $229.0K | -$43.0K | $121.0K | $481.0K | $273.0K |
| Cost Of Revenue | $422.0K | $601.0K | $480.0K | $502.0K | $603.0K | $711.0K | $696.0K |
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | $5.3M | $7.6M | $8.9M | $10.0M | $11.0M | $10.8M | $12.6M |
| Other Nonoperating Income Expense | -$5.0K | -$49.0K | $161.0K | $100.0K | $310.0K | $97.0K | |
| Income Tax Expense Benefit | $2.0K | $0.00 | $4.0K | $0.00 | -$1.0K | $0.00 | $1.0K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$4.7M | -$7.7M | -$8.5M | -$10.2M | -$12.1M | -$10.4M | -$12.0M |
| Comprehensive Income Net Of Tax | |||||||
| Net Income Loss Available To Common Stockholders Basic |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | $30.6M | $71.5M | $15.9M | $8.6M | -$502.0K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $41.3M | $65.1M | |||||
| Performance Of Contract Liability To Affiliate | $0.00 | $19.0K | $115.0K | $970.0K | $0.00 | ||
| Cash And Cash Equivalents At Carrying Value | $24.7M | $41.3M | $65.1M | $13.3M | $8.2M | $82.0K | |
| Retained Earnings Accumulated Deficit | -$178.3M | -$132.7M | -$87.4M | -$52.7M | -$42.9M | ||
| Property Plant And Equipment Net | $1.0M | $1.4M | $2.5M | $1.7M | $278.0K | ||
| Prepaid Expense And Other Assets Current | $1.4M | $2.4M | $993.0K | $551.0K | $227.0K | ||
| Liabilities Current | $16.1M | $11.8M | $7.1M | $3.3M | $1.1M | ||
| Liabilities And Stockholders Equity | $30.6M | $50.1M | $78.6M | $20.9M | $9.7M | ||
| Liabilities | $23.7M | $19.5M | $7.1M | $5.0M | $1.1M | ||
| Common Stock Value | $286.0K | $228.0K | $220.0K | $179.0K | $162.0K | ||
| Assets Current | $26.9M | $44.8M | $66.8M | $14.8M | $9.4M | ||
| Assets | $30.6M | $50.1M | $78.6M | $20.9M | $9.7M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$1.5M | -$915.0K | $8.3M | -$1.2M | -$822.0K | ||
| Accrued Liabilities Current | $6.6M | $3.1M | $4.6M | $683.0K | $832.0K | ||
| Additional Paid In Capital Common Stock | $186.5M | $164.0M | $150.4M | $69.7M | $52.1M | ||
| Accrued Expenses Related Party Current | $2.0M | $1.5M | $224.0K | ||||
| Accounts Receivable Net Current | $776.0K | $901.0K | $594.0K | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$20.0M | -$16.7M | -$23.8M | ||||
| Accounts Payable Current | $1.4M | $1.4M | $2.2M | $317.0K | |||
| Reversal Of Kantaro Liability | $0.00 | $55.0K | $119.0K | $495.0K | |||
| Convertible Notes Payable Current | $4.5M | $4.7M | |||||
| Convertible Long Term Notes Payable | $7.5M | $7.7M | |||||
| Operating Lease Liability Current | $130.0K | $0.00 | |||||
| Fair Value Adjustments To Convertible Debt | $3.5M | $2.0M | -$4.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$11.3M | -$7.9M | -$11.1M | -$8.0M | -$1.5M | $7.0M | $18.1M | $8.9M | $18.8M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $909.0K | $4.7M | $4.7M | $5.6M | $13.9M | $24.7M | $33.0M | $23.8M | $31.0M |
| Performance Of Contract Liability To Affiliate | $0.00 | $0.00 | $0.00 | $0.00 | $7.0K | $12.0K | |||
| Cash And Cash Equivalents At Carrying Value | $909.0K | $4.7M | $4.7M | $5.6M | $13.9M | ||||
| Retained Earnings Accumulated Deficit | -$216.5M | -$211.8M | -$204.7M | -$197.0M | -$188.5M | ||||
| Property Plant And Equipment Net | $202.0K | $216.0K | $230.0K | $576.0K | $944.0K | ||||
| Prepaid Expense And Other Assets Current | $1.1M | $716.0K | $1.1M | $1.3M | $1.6M | ||||
| Liabilities Current | $12.0M | $11.5M | $15.0M | $13.9M | $15.2M | ||||
| Liabilities And Stockholders Equity | $4.8M | $8.0M | $8.8M | $11.3M | $19.5M | ||||
| Liabilities | $16.1M | $15.8M | $19.9M | $19.2M | $21.0M | ||||
| Common Stock Value | $515.0K | $478.0K | $368.0K | $305.0K | $290.0K | ||||
| Assets Current | $2.9M | $6.1M | $6.3M | $8.3M | $16.5M | ||||
| Assets | $4.8M | $8.0M | $8.8M | $11.3M | $19.5M | ||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$2.0M | -$1.4M | -$1.6M | -$1.7M | -$1.3M | ||||
| Accrued Liabilities Current | $2.2M | $3.4M | $4.3M | $4.3M | $4.6M | ||||
| Additional Paid In Capital Common Stock | $206.7M | $204.9M | $194.8M | $190.4M | $188.0M | ||||
| Accrued Expenses Related Party Current | $102.0K | $1.3M | $1.1M | $3.7M | $2.5M | ||||
| Accounts Receivable Net Current | $902.0K | $722.0K | $554.0K | $1.4M | $1.0M | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$3.8M | -$10.8M | -$10.3M | ||||||
| Accounts Payable Current | |||||||||
| Reversal Of Kantaro Liability | $0.00 | $12.0K | |||||||
| Convertible Notes Payable Current | $4.1M | $4.2M | $4.4M | $3.1M | $4.6M | ||||
| Convertible Long Term Notes Payable | $4.1M | $4.3M | $4.9M | $5.3M | $5.8M | ||||
| Operating Lease Liability Current | $11.0K | $45.0K | $78.0K | $111.0K | $131.0K | ||||
| Fair Value Adjustments To Convertible Debt | $762.0K | $945.0K | $921.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $1.7M | $2.9M | $4.6M | $2.7M | $1.2M | $525.0K |
| Net Cash Provided By Used In Operating Activities | -$30.1M | -$34.1M | -$45.9M | -$28.4M | -$9.5M | -$6.2M |
| Net Cash Provided By Used In Financing Activities | $10.3M | $16.4M | $25.6M | $77.2M | $15.9M | $27.4M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$798.0K | -$1.3M | $1.5M | $710.0K | $325.0K | $197.0K |
| Increase Decrease In Accrued Liabilities | -$3.4M | $3.4M | -$1.5M | $4.4M | -$456.0K | $221.0K |
| Share Based Compensation | $1.7M | $2.9M | $4.6M | $2.7M | $1.2M | $525.0K |
| Net Cash Provided By Used In Investing Activities | -$4.0K | $0.00 | -$662.0K | -$751.0K | -$1.2M | -$12.3M |
| Depreciation Depletion And Amortization | $364.0K | $508.0K | $489.0K | $282.0K | $70.0K | $31.0K |
| Increase Decrease In Accrued Expenses Related Party | -$635.0K | $451.0K | $1.3M | $585.0K | ||
| Increase Decrease In Accounts Receivable | -$54.0K | -$125.0K | $307.0K | $594.0K | ||
| Proceeds From The Issuance Of Ordinary Shares Under Employee Share Purchase Plan | 93.0K | 261.0K | 209.0K | 111.0K | ||
| Increase Decrease In Deferred Revenue | $0.00 | -$46.0K | -$76.0K | $122.0K | ||
| Payments To Acquire Property Plant And Equipment | $0.00 | $557.0K | $773.0K | $804.0K | $309.0K | |
| Increase Decrease In Accounts Payable Trade | $106.0K | $80.0K | $1.4M | |||
| Increase Decrease In Accounts Payable Related Parties | -$433.0K | $368.0K | $722.0K | |||
| Payments To Develop Software | $0.00 | $105.0K | $749.0K | $427.0K | ||
| Increase Decrease In Due To Affiliates | $0.00 | -$176.0K | -$970.0K | -$185.0K | ||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$137.0K | $1.0M | -$2.8M | |||
| Proceeds From Issuance Of Common Stock | $13.5M | $20.3M | $8.8M | $17.3M | $29.1M | |
| Increase Decrease In Due From Affiliates Current | $0.00 | -$75.0K | -$1.0K | -$17.0K | $18.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $254.0K | $385.0K | $385.0K | $524.0K | $770.0K | $818.0K | $763.0K |
| Net Cash Provided By Used In Operating Activities | -$3.8M | -$9.5M | -$7.1M | ||||
| Net Cash Provided By Used In Financing Activities | $0.00 | -$1.1M | -$944.0K | ||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $327.0K | $153.0K | -$312.0K | ||||
| Increase Decrease In Accrued Liabilities | -$1.3M | -$2.1M | -$125.0K | ||||
| Share Based Compensation | $254.0K | $523.0K | $767.0K | ||||
| Net Cash Provided By Used In Investing Activities | $23.0K | $0.00 | $0.00 | ||||
| Depreciation Depletion And Amortization | $60.0K | $127.0K | $130.0K | ||||
| Increase Decrease In Accrued Expenses Related Party | -$1.2M | $579.0K | $22.0K | ||||
| Increase Decrease In Accounts Receivable | $154.0K | $238.0K | $322.0K | ||||
| Proceeds From The Issuance Of Ordinary Shares Under Employee Share Purchase Plan | 0.00 | 116.0K | |||||
| Increase Decrease In Deferred Revenue | $0.00 | -$7.0K | |||||
| Payments To Acquire Property Plant And Equipment | |||||||
| Increase Decrease In Accounts Payable Trade | $1.6M | $250.0K | $555.0K | ||||
| Increase Decrease In Accounts Payable Related Parties | $1.4M | $202.0K | $1.3M | ||||
| Payments To Develop Software | |||||||
| Increase Decrease In Due To Affiliates | |||||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $42.0K | -$222.0K | -$2.2M | ||||
| Proceeds From Issuance Of Common Stock | |||||||
| Increase Decrease In Due From Affiliates Current | $0.00 | $13.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.31 | -$0.55 | -$0.67 | -$0.49 | -$0.17 | -$0.99 |
| Common Stock Shares Issued | 93.8M | 74.8M | 72.2M | 59.4M | ||
| Weighted Average Number Of Shares Outstanding Basic | 108.2M | 82.2M | 72.9M | 71.5M | 59.1M | |
| Weighted Average Number Of Diluted Shares Outstanding | 108.2M | 82.2M | 73.8M | 71.5M | 59.1M | |
| Earnings Per Share Basic | $-0.31 | $-0.55 | $-0.62 | $-0.49 | $-0.17 | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Common Stock Shares Outstanding | 93.8M | 74.8M | 72.2M | 59.4M | ||
| Common Stock Shares Authorized | 161.8M | 98.8M | 79.3M | 62.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.04 | -$0.08 | -$0.09 | -$0.11 | -$0.14 | -$0.14 | -$0.16 | |
| Common Stock Shares Issued | 165.9M | 154.4M | 119.9M | 99.9M | 93.8M | |||
| Weighted Average Number Of Shares Outstanding Basic | 105.7M | 97.7M | 97.3M | 94.8M | 85.6M | 74.9M | 74.8M | |
| Weighted Average Number Of Diluted Shares Outstanding | 105.7M | 97.7M | 97.3M | 94.8M | 85.6M | 74.9M | 74.8M | |
| Earnings Per Share Basic | $-0.04 | $-0.08 | $-0.09 | $-0.11 | $-0.14 | $-0.14 | $-0.16 | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Common Stock Shares Outstanding | 165.9M | 154.4M | 119.9M | 99.9M | 93.8M | |||
| Common Stock Shares Authorized | 173.8M | 173.8M | 128.0M | 107.2M | 102.5M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Foreign Currency Transaction Gain Loss Before Tax | $163.0K | $358.0K | $9.7M | -$8.8M | $245.0K | $20.0K |
| Fair Value Adjustment To Vericidx Investment | $505.0K | $1.3M | $5.9M | -$6.5M | $0.00 | |
| Fair Value Adjustment To Convertible Notes | $3.8M | $3.1M | -$4.0M | $0.00 | $0.00 | |
| Changes In Fair Value Of Convertible Notes | $305.0K | -$337.0K | $536.0K | $0.00 | $0.00 | |
| Foreign Currency Transaction Gain Loss Unrealized | $0.00 | $1.0M | $7.3M | -$5.5M | $213.0K | |
| Payment Of Financing And Stock Issuance Costs | $1.7M | $991.0K | $218.0K | $2.3M | $1.6M | $1.3M |
| Stock Issued During Period Value Employee Stock Purchase Plan | $93.0K | $261.0K | $209.0K | $111.0K | ||
| Payment Of Convertible Notes Principal | $1.7M | $3.2M | $0.00 | |||
| Due To Affiliate Current | $55.0K | $350.0K | $271.0K | |||
| Changes In The Fair Value Of The Convertible Notes | $305.0K | -$337.0K | $536.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|
| Foreign Currency Transaction Gain Loss Before Tax | $37.0K | $15.0K | -$89.0K | $289.0K | -$461.0K | -$108.0K | $1.7M |
| Fair Value Adjustment To Vericidx Investment | -$97.0K | -$40.0K | -$202.0K | $447.0K | -$129.0K | $345.0K | $854.0K |
| Fair Value Adjustment To Convertible Notes | $762.0K | $1.2M | $114.0K | $1.2M | $1.2M | $440.0K | $1.2M |
| Changes In Fair Value Of Convertible Notes | -$125.0K | $155.0K | $0.00 | $75.0K | $593.0K | -$920.0K | $397.0K |
| Foreign Currency Transaction Gain Loss Unrealized | $0.00 | -$456.0K | |||||
| Payment Of Financing And Stock Issuance Costs | $0.00 | $5.0K | |||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $93.0K | $145.0K | $116.0K | ||||
| Payment Of Convertible Notes Principal | $0.00 | $1.1M | $1.1M | ||||
| Due To Affiliate Current | |||||||
| Changes In The Fair Value Of The Convertible Notes | -$125.0K | $155.0K | $75.0K | $505.0K | -$920.0K | $397.0K |
Most recent annual filing with the SEC: September 30, 2024
Data sourced from SEC EDGAR public filings as of August 7, 2026.